奥赛康：12月27日召开董事会会议

Group 1 - The core point of the article is that Aosaikang (SZ 002755) held its seventh board meeting on December 27, 2025, to discuss the signing of a licensing agreement [1] - Aosaikang's revenue composition for the year 2024 is reported to be 97.92% from the pharmaceutical manufacturing sector and 2.08% from other businesses [1] - As of the report, Aosaikang's market capitalization stands at 15.1 billion yuan [1]